BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32800688)

  • 1. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?
    Demir T; Aliyev A; Beşiroğlu M; Araz M; Köstek O; Sakin A; Shbair ATM; Çoban G; Ersöz C; Şeker M; Türk HM
    Curr Probl Cancer; 2021 Feb; 45(1):100619. PubMed ID: 32800688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
    Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
    Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis.
    Luo X; Li JX; Liu YT; Zou G; Yao WX; Qing GQ; Yang RL; Ye XY; Facchini G; Rossetti S
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6079-6090. PubMed ID: 31364109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of lymph node dissection in patients with ≥7-cm renal tumors.
    Feuerstein MA; Kent M; Bazzi WM; Bernstein M; Russo P
    World J Urol; 2014 Dec; 32(6):1531-6. PubMed ID: 24402173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma.
    Chapman TN; Sharma S; Zhang S; Wong MK; Kim HL
    Urology; 2008 Feb; 71(2):287-91. PubMed ID: 18308105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
    Wei Y; Wang M; Jin Y; Zhou C; Lyu J
    World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European temporal trends in the use of lymph node dissection in patients with renal cancer.
    Capitanio U; Stewart GD; Larcher A; Ouzaid I; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Salagierski M; Volpe A; Mir MC; Kriegmair M; Terrone C; Brookman-May SD; Montorsi F; Klatte T;
    Eur J Surg Oncol; 2017 Nov; 43(11):2184-2192. PubMed ID: 28801061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.
    Chipollini J; Abel EJ; Peyton CC; Boulware DC; Karam JA; Margulis V; Master VA; Zargar-Shoshtari K; Matin SF; Sexton WJ; Raman JD; Wood CG; Spiess PE
    Clin Genitourin Cancer; 2018 Apr; 16(2):e443-e450. PubMed ID: 29113770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma.
    Simmons MN; Kaouk J; Gill IS; Fergany A
    Urology; 2007 Jul; 70(1):43-6. PubMed ID: 17656205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
    Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
    Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
    Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis.
    Kokorovic A; Breau RH; Kapoor A; Finelli A; So AI; Lavallee LT; Tanguay S; Pouliot F; Drachenberg DE; Fairey A; Lattouf JB; Kawakami J; Wood L; Mallick R; Rendon RA
    Urol Oncol; 2021 Jun; 39(6):371.e17-371.e25. PubMed ID: 33785219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
    Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
    Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.
    Kates M; Lavery HJ; Brajtbord J; Samadi D; Palese MA
    Ann Surg Oncol; 2012 Aug; 19(8):2693-9. PubMed ID: 22526899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
    Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR
    Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.
    Srivastava A; Rivera-Núñez Z; Kim S; Sterling J; Farber NJ; Radadia KD; Patel HV; Modi PK; Goyal S; Parikh R; Mayer TM; Saraiya B; Sadimin ET; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
    Cancer; 2020 Jul; 126(13):2991-3001. PubMed ID: 32329899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.